CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post TAVR coronary access. 

COMPARE TAVI: Resultados al año de un estudio aleatorizado que compara dos válvulas balón expandibles

The aim of this study was to assess the capacity for coronary cannulation after TAVR using Evolut FX with adequately positioned golden markers (aligned commissures). It also looked at the impact of commissural and coronary alignment with coronary CT. 

This was a multicenter study carried out in centers of US and Japan including consecutive patients with severe aortic stenosis implanted with the Evolut FX, receiving coronary angiogram and CT immediately after procedure. 

A total of 126 patients were included, mean age 81. Success cannulation rate of the left coronary (within the first 10 minutes) was 100%, while the right coronary reached 96.7%.

Read also: TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation.

At post implantation CT, most cases presented correct commissural alignment, though 25.4% showed mild misalignment. Anatomical factors associated with failed cannulation were evaluated and left main height and left commissural misalignment were identified as the main causes. On the other hand, predictors of failed right coronary artery cannulation were Valsalva sinuses width and commissural misalignment.

Presented by Yohei Ohno at Top Late-Breaking Trials, PCR London Valves, November 24, 2024, London, Great Britain.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

Más artículos de este Autor

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas Panamá 2026
Jornadas SOLACIspot_img

Artículos recientes

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

We invite you to submit scientific papers and challenging clinical cases for the SOLACI & SBHCI 2026 Congress, taking place from July 29 to...

Watch again “Ultrasound Pulses + Calcium = Coronary Lithotripsy” | SOLACI Technicians Webinar

The webinar “Ultrasound Pulses + Calcium = Coronary Lithotripsy”, held on March 24, 2026 via the Zoom platform, is now available for viewing on...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...